BIOHITECH GLOBAL, INC.·4

Nov 23, 3:44 PM ET

BIOHITECH GLOBAL, INC. 4

4 · BIOHITECH GLOBAL, INC. · Filed Nov 23, 2016

Insider Transaction Report

Form 4
Period: 2016-11-18
Transactions
  • Exercise of In-Money

    Convertible Promissory Note

    2016-11-18$250000.00/sh+1$250,0001 total
    Exercise: $2.75From: 2016-11-18Exp: 2018-11-18Common Stock (90,910 underlying)
  • Exercise of In-Money

    Warrants

    2016-11-18+90,91090,910 total
    Exercise: $3.30From: 2016-11-18Exp: 2021-11-18Common Stock (90,910 underlying)
Footnotes (5)
  • [F1]Represents the highest possible conversion price of the note.
  • [F2]Represents the number of shares of common stock, par value $0.001 per share (the "Common Stock") into which the note is convertible based on the conversion price of $2.75 per share. The note is convertible into an indeterminable number of shares.
  • [F3]Does not include 32,451 shares of common stock held by the reporting person, a convertible promissory note which is convertible into approximately 26,667 shares of common stock held by Conundrum Capital Partners, LLC ("Conundrum"), warrants held by Conundrum which are exercisable for approximately 26,667 shares of common stock, or 837,296 shares of common stock held by Conundrum over which Mr. Chambers holds voting and dispositive power. The address for Conundrum is 317 Eatons Landing Drive, Annapolis, MD 21401.
  • [F4]Based upon 120% of the conversion price of $2.75 per share. The warrants are exercisable into an indeterminable number of shares.
  • [F5]Represents the number of shares of Common Stock into which the warrants are exercisable based on the exercise price of $3.30 per share.

Documents

1 file
  • 4
    v453879_4.xmlPrimary

    OWNERSHIP DOCUMENT